Moscow, Russian Federation
Moscow, Russian Federation
Moscow, Russian Federation
GRNTI 76.03 Медико-биологические дисциплины
GRNTI 76.33 Гигиена и эпидемиология
OKSO 14.04.02 Ядерные физика и технологии
OKSO 31.06.2001 Клиническая медицина
OKSO 31.08.08 Радиология
OKSO 32.08.12 Эпидемиология
BBK 51 Социальная гигиена и организация здравоохранения. Гигиена. Эпидемиология
BBK 534 Общая диагностика
TBK 5708 Гигиена и санитария. Эпидемиология. Медицинская экология
TBK 5712 Медицинская биология. Гистология
TBK 5734 Медицинская радиология и рентгенология
TBK 6212 Радиоактивные элементы и изотопы. Радиохимия
Purpose: Is to demonstrate functional and structural changes in the musculoskeletal system of the patient with ochronosis using bone scan and hybrid imaging consisting of single-photon emission computed tomography (SPECT) and X-ray transmission computed tomography (CT) scan (SPECT/CT). Material and methods: A clinical case report of patient with ochronosis, examined with bone scan and SPECT/CT. Results: In this article we show a clinical case with the picture of mineral metabolism disorder and severe degenerative changes of musculoskeletal system in patient with ochronosis (a genetically determined disease), caused by metabolic disorders of homogentisic acid. We used hybrid SPECT/CT method for evaluation of this disease. Conclusion: SPECT/CT method demonstrated structural and metabolic changes. This method allowed us to reveal the specific changes in cases of ochronosis, but also it shows the possibility of using radionuclide methods in solving non-standard situations, while this method has not previously been applied.
ochronosis, bone scan, SPECT/CT
1. Mannoni A, Selvi E, Lorenzini S, Giorgi M, Airó P, Cammelli D, Andreotti L, Marcolongo R, Porfirio B. Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum. 2004;33(4):239-48. DOI:https://doi.org/10.1053/s0049-0172(03)00080-5.
2. Zatkova A. An update on molecular genetics of Alkaptonuria (AKU). J Inherit Metab Dis. 2011;34(6):1127-36. DOI:https://doi.org/10.1007/s10545-011-9363-z.
3. Taylor AM, Boyde A, Wilson PJ, Jarvis JC, Davidson JS, Hunt JA, Ranganath LR, Gallagher JA. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum. 2011;63(12):3887-96. DOI:https://doi.org/10.1002/art.30606.
4. Araki K, Sudo A, Hasegawa M, Uchida A. Devastating ochronotic arthropathy with successful bilateral hip and knee arthroplasties. J Clin Rheumatol. 2009;15(3):138-40. DOI:https://doi.org/10.1097/RHU.0b013e31819e6b41.
5. Aquaron R. Alkaptonuria: a very rare metabolic disorder. Indian J Biochem Biophys. 2013;50(5):339-44.
6. Gallagher JA, Dillon JP, Sireau N, Timmis O, Ranganath LR. An example of a “fundamental disease” - A rare disease with important lessons for more common disorders. Semin Cell Dev Biol. 2016;52:53-7. DOI:https://doi.org/10.1016/j.semcdb.2016.02.020.
7. Perrone A, Impara L, Bruni A, Primicerio P, Marini M. Radiographic and MRI findings in ochronosis. Radiol Med. 2005;110(4):349-58.
8. Doganavsargil B, Pehlivanoglu B, Bicer EK, Argin M, Bingul KB, Sezak M, et al. Black joint and synovia: histopathological evaluation of degenerative joint disease due to ochronosis. Pathol Res Pract. 2015;21(6);470-7. DOI:https://doi.org/10.1016/j.prp.2015.03.001.
9. Ranganath LR, Cox TF Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis. 2011;34 (6):1141-51. DOI:https://doi.org/10.1007/s10545-011-9374-9.
10. Nasonova VA, Bunchuk NV (Ed.) Rheumatic Diseases: A Guide for Physicians. M.: Medicine. 1997. 520 p. (in Russ.).
11. Clipell DH, Stone DH, Crofford LJ, White PH. Ed by Nasonov EL, Nasonov VA, Olyunin YuA (trans). Rheumatic Diseases. Manual in 3 volumes. Vol. 2. Bone and Joint Diseases. M.: GEOTAR-Media, 2012. 520 p. (in Russ.).
12. Bashkova IB, Kichigin VA, Bezludnaya NV, Stepanov EG, Kovalev DV, Karpuhin AS, Tarasov AN. Ochronosis: difficulties in diagnosing in clinician’s practice. Difficult Patient. 2016;14(10-11):40-5. (in Russ.).
13. Chepoy VM. Diagnosis and Treatment of Diseases of the Joints. M.: Medicine. 1990. 304 p. (in Russ.).
14. Grigorovskiy VV, Babko AN. Differential Diagnosis and Treatment of Ochronotic Arthropathy. (Case report and current state review). N.N. Priorov Bulletin of Traumatology and Ortopedics. 2006;(4):42-8. (in Russ.).
15. Ventura-Ríos L, Hernández-Díaz C, Gutiérrez-Pérez L, Bernal-González A, Pichardo-Bahena R, Cedeño-Garcidueñas AL, Pineda C. Ochronotic arthropathy as a paradigm of metabolically induced degenerative joint disease. A case-based review. Clin Rheumatol. 2016;35(5):1389-95. DOI:https://doi.org/10.1007/s10067-014-2557-7.
16. Bashkova IB, Kichigin VA, Shaipov RSh, Kryuchkov NA, Bezlyudnaya NV, Didichenko SN, Borisova LV. Ochronosis as a cause of secondary osteoarthrosis. RMJ. 2017;25(7):474-80. (in Russ.).
17. Zolovkina AG, Suprun EA, Dzhukhaev DA, Lobanov MN, Abdaljan AM. Alkaptonuric ochronosis in endoprosthesis replacement of large joints. Laboratory Service. 2018;7(3-2):95. (in Russ.).
18. Zhao BH, Chen BC, Shao DC, Zhang Q Osteoarthritis? Ochronotic arthritis! A case study and review of the literature. Knee Surg Sports Traumatol Arthrosc. 2009;17(7):778-81. DOI:https://doi.org/10.1007/s00167-009-0778-0.
19. Avdeeva OS, Belyaeva EA, Dubrovina YuS, Nikishina OA, Savenkova NA, Yushina TA. Secondary osteoarthritis in case of ochronosis combined with osteoporosis. Journal of New Medical Technologies. 2008;15 (3):90-1. (in Russ.).
20. Chernov VI, Bragina OD, Sinilkin IG, Medvedeva AA, Zel’chan RV. Radionuclide teranostic of malignancies. Journal of Radiology and Nuclear Medicine. 2016;97(5):306-13. (in Russ.).
21. Krylov AS, Ryzhkov AD, Shchipakhina YA, Nered AS, Bludov AB, Shiryaev SV. The role of SPECT/CT and MRI in the differential diagnosis of skeletal damage (case report). Medical Radiology and Radiation Safety. 2019;64(1):69-73. (in Russ.). DOI:https://doi.org/10.12737/article_5c55fb5ef00a68.52703915.
22. Ryzhkov AD, Krylov AS, Bludov AB, Shiryaev SV Osteoscintigraphy and SPECT/CT in the diagnosis of various variants of bone metastases. Medical Radiology and Radiation Safety. 2018;63(2):41-6. (in Russ.). DOI:https://doi.org/10.12737/article_5ac61fd62feba6.78437892.
23. Chernov VI, Bragina OD, Sinilkin IG, Medvedeva AA, Zelchan RV. Radioimmunotherapy: Current state of the problem. Problems of Oncology. 2016;62(1):24-30. (in Russ.).
24. Ryzhkov AD, Krylov AS, Shiryaev SV, Shchipakhina YaA, Kochergina NV. The advantage of a combined SPECT/CT in the diagnosis of bone metastases. Medical Radiology and Radiation Safety. 2017;62(5):33-9. (in Russ.). DOI:https://doi.org/10.12737/article_59f2fc0812bc46.45377149.
25. Chernov VI, Triss SV, Skuridin VS, Lishmanov YB Thallium-199: A new radiopharmaceutical for myocardial perfusion imaging. Int J Card Imaging 1996;12(2):119-26.
26. Lishmanov Y, Minin S, Efimova I, Chernov V, Saushkina Y, Lebedev D, Popov S. The possible role of nuclear imaging in assessment of the cardiac resynchronization therapy effectiveness in patients with moderate heart failure. Ann Nucl Med. 2013;27(4):378-85.
